CompletedNot Applicable

First Trimester Prediction of Preeclampsia and Fetal Growth Restriction

United States1,200 participantsStarted 2013-03

Plain-language summary

To evaluate the feasibility of screening for preeclampsia and fetal growth restriction between 11-13+6 weeks' gestation utilizing the combination of uterine artery doppler, maternal blood pressure, maternal characteristics, placental volume, and maternal serum factors, including PAPPA-A, PLGF, AFP and free Beta HCG. This is a non interventional study.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All patients during their first trimester visit Exclusion Criteria: Fetal anomalies Pregnancies ending in termination, miscarriage or fetal death prior to 22 weeks and cases with no pregnancy follow up.

What they're measuring

Development of Preeclampsia

Timeframe: During the first trimester (11-13+6 weeks)

Trial details

NCT IDNCT02379494

SponsorFetal Medicine Foundation

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-01-01

View on ClinicalTrials.gov More Preeclampsia trials